tiprankstipranks
Blurbs

SVB Securities Reaffirms Their Buy Rating on Tango Therapeutics (TNGX)

SVB Securities analyst Andrew Berens maintained a Buy rating on Tango Therapeutics (TNGXResearch Report) yesterday. The company’s shares closed yesterday at $6.84.

Berens covers the Healthcare sector, focusing on stocks such as BeiGene, Zymeworks, and AstraZeneca. According to TipRanks, Berens has an average return of 2.0% and a 46.41% success rate on recommended stocks.

Tango Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $15.50.

See the top stocks recommended by analysts >>

TNGX market cap is currently $633.1M and has a P/E ratio of -6.23.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

BCTG Acquisition Corp is a blank check company.

Read More on TNGX:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles